IP Verse

Meritage Pharma, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Meritage Pharma, Inc. opposed by its competitors

Patent:
EP3574914
Grant Date:
Dec 29, 2021
Title:
Corticosteroid Compositions
Oppositions:
1
Patent:
EP2585075
Grant Date:
Sep 22, 2021
Title:
Methods Of Treatment For Esophageal Inflammation
Oppositions:
1
Patent:
EP3354276
Grant Date:
Jan 1, 2020
Title:
Compositions For The Treatment Of Gastrointestinal Inflammation
Oppositions:
2
Patent:
EP2214679
Grant Date:
Mar 27, 2019
Title:
Corticosteroid Compositions
Oppositions:
2
Patent:
EP2211896
Grant Date:
Jan 3, 2018
Title:
Compositions For The Treatment Of Gastrointestinal Inflammation
Oppositions:
2
Patent:
EP2214677
Grant Date:
Aug 30, 2017
Title:
Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract
Oppositions:
1

Competitors of Meritage Pharma, Inc.

DR. FALK PHARMA GMBH

AECHTER, BERND

PRUFER & PARTNER MBB

Want to track Meritage Pharma, Inc.?

Feel free to send us a message here and we will get back to you